首页|1例雷贝拉唑钠肠溶胶囊致肌张力障碍分析

1例雷贝拉唑钠肠溶胶囊致肌张力障碍分析

扫码查看
目的 提醒临床使用雷贝拉唑钠肠溶胶囊时注意肌张力障碍的不良反应.方法 根据患者的临床表现及药物与用药时间的关联性,分析 1 例由雷贝拉唑钠肠溶胶囊导致的肌张力障碍的病例.结果 肌张力障碍可能是雷贝拉唑钠肠溶胶囊新的不良反应.结论 临床初次使用雷贝拉唑钠肠溶胶囊的患者应关注肌张力障碍不良反应.
One case of dystonia shock caused by Rabeprazole Sodium Delayed-release Capsules
Objective To alert clinicians to adverse drug reactions of dystonia induced by Rabeprazole Sodium Delayed-release Capsules.Methods The clinical data of one case of dystonia shock caused by Rabeprazole Sodium Delayed-re-lease Capsules was analyzed while literature related to the drug adverse reactions.Results Dystonia adverse drug reactions are Rabeprazole Sodium Delayed-release Capsules-induced new adverse drug reactions.Conclusion Dystonia adverse re-actions should be paid attention to in patients who first use Rabeprazole Sodium Delayed-release Capsule.

Rabeprazole Sodium Delayed-release CapsulesDystoniaAdverse drug reaction

董琼、许文成

展开 >

湖北省中医院,湖北中医药大学附属医院,湖北省中医药研究院,湖北 武汉 430061

雷贝拉唑钠肠溶胶囊 肌张力障碍 药品不良反应

武汉市中青年医学骨干人才培养工程

武卫通[2020]55号

2024

药学研究
山东省药品检验所 山东省药学会

药学研究

CSTPCD
影响因子:0.653
ISSN:2095-5375
年,卷(期):2024.43(4)
  • 16